Exicure, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Exicure, Inc. Website Screenshot

http://www.exicuretx.com

Exicure, Inc. Company Intro

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for immuno-oncology, genetic disorders, and other indications. Its three clinical programs include AST-008, which is in a Phase I clinical trial, an SNA consisting of toll-like receptor 9 that is designed for immuno-oncology applications; XCUR17, which is in a Phase I clinical trial, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha, a protein that helps in the initiation and maintenance of psoriasis; and AST-005, which is in a Phase I clinical trial, an SNA that targets TNF for the treatment of mild to moderate psoriasis. Exicure, Inc. has collaboration agreements with Allergan plc; DERMELIX, LLC; and Purdue Pharma L.P. The company was founded in 2011 and is headquartered in Skokie, Illinois.

Industry

Healthcare

Exicure, Inc. Headquaters

8045 Lamon Avenue
Skokie,60077
United States


Exicure, Inc. Share price

22 Jan 2021 02:54 GMT

$2.3500

0.08 (3.52 %)


Exicure, Inc. Market cap

$202.353 M


WMC RANKING

2021

Exicure, Inc. # 153

Biotechnology

Latest Exicure, Inc. News

News 08 Jan 2021

Global Interleukin 1 (IL1) Market 2020 Insights, Share, Growth ...

Exicure Inc Immune Response BioPharma Inc ... As a market research company, we take pride in equipping our clients with insights and data that holds the ...

News 08 Jan 2021

Interleukin 1 (IL1) Market Trends, Top Manufactures ...

Competitive dashboard: Optimum Therapeutics LLC, Cell Medica Ltd, AbbVie Inc, ... Inc, TWi Biotechnology Inc, Swedish Orphan Biovitrum AB, Exicure Inc, ...

News 08 Jan 2021

Global Interleukin 1 (IL1) Market 2020 Insights, Share, Growth ...

Exicure Inc Immune Response BioPharma Inc ... As a market research company, we take pride in equipping our clients with insights and data that holds the ...


WMC Market Score


WMC Market to Revenue Score


Exicure, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Exicure, Inc. USD $16,783 $39,868 $-21,964 $2,024M 153
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $571,390B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $345,270B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $620,550B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $271,640B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Exicure, Inc. Social Followers vs Top 4 Industry Competitors



Exicure, Inc. Post vs Top 4 Industry Competitors




Exicure, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Exicure, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Exicure, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Exicure, Inc. 0.18 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 66.33 29.44 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.28 100 60 0 0 90.10
Vertex Pharmaceuticals Incorporated 64.81 100 8.77 86 0 0 99.40
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries